Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IGM-2323 |
Trade Name | |
Synonyms | IGM2323|IGM 2323|Imvotamab |
Drug Descriptions |
IGM-2323 is a bispecific antibody that binds to CD3 and CD20, which potentially induces cytotoxicity against cancer cells expressing CD20 (Blood (2019) 134 (Suppl._1): 1574). |
DrugClasses | CD20 Antibody 24 CD3 Antibody 99 |
CAS Registry Number | 2573121-53-4 |
NCIT ID | C165166 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IGM-2323 | IGM-2323 | 0 | 1 |